Dev Labtech Venture Limited has made a regulatory disclosure pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This disclosure follows the company's earlier intimation dated October 7, 2026.

Key Approval Details

In the Extra Ordinary General Meeting of the Company held on November 5, 2026, the Members approved the issuance of up to 1,37,00,000 (One Crore Thirty-Seven Lakh) Convertible Warrants to Promoter/Promoter Group and Non-Promoters of the Company on a preferential basis.

Issue Details

  • Type of Security: Convertible Warrants
  • Issue Type: Preferential Issue
  • Total Number of Warrants: 1,37,00,000
  • Issue Price: ₹13 per warrant
  • Conversion Terms: Each warrant convertible into one equity share of face value ₹5 with premium of ₹8
  • Total Issue Size: ₹17,81,00,000 (Seventeen Crore Eighty-One Lakh)
  • Number of Investors: 7

Investor Allocation

The warrants were allocated to the following investors as detailed in Annexure I:

| Investor Name | Category | Number of Warrants | Amount (₹) |

| Donda Jerambhai Lavjibhai | Promoter | 27,00,000 | 3,51,00,000 |

| Donda Labhuben Jerambhai | Promoter | 27,00,000 | 3,51,00,000 |

| Jaykumar J Donda | Promoter | 26,96,000 | 3,50,48,000 |

| Donda Jerambhai Lavjibhai HUF | Promoter Group | 26,96,000 | 3,50,48,000 |

| Vanrajsinh Boghubha Sarvaiya | Non-Promoter | 14,16,000 | 1,84,08,000 |

| Rajendrasinh Hathisinh Sarvaiya | Non-Promoter | 14,16,000 | 1,84,08,000 |

| Sachin Madhusudan Chhatre | Non-Promoter | 76,000 | 9,88,000 |

| Total | - | 1,37,00,000 | 17,81,00,000 |

Post-Allotment Impact

Pursuant to the allotment, the issued, subscribed and paid-up share capital of the Company stands increased. The post-allotment shareholding pattern shows:

  • Promoter/Promoter Group: 61.64%
  • Non-promoter: 38.36%

Conversion Terms

The warrants have a tenor of 18 months from the date of their allotment and are convertible into equity shares in one or more tranches. Each warrant is exercisable into one equity share of face value ₹5.